Estimation Of Potential Gain In Quality Of Life From Early Detection Of Cervical Cancer

Published Apr 28, 2014
Tainan, Taiwan - Each year, about 528,000 new cases of cervical cancer are reported worldwide. In Taiwan, a screening program exists for early detection, which can save life-years for those individuals who are affected, but the effect on quality of life still remains to be quantified. In the article, “Estimation of Potential Gain in Quality of Life from Early Detection of Cervical Cancer,” published in Value in Health, investigators abstracted data of 22,543 new cases of invasive cervical cancer (ICC) from the Taiwan National Cancer Registry to estimate the lifetime survival function, as well as a consecutive, cross-sectional sample of 421 patients with ICC or carcinoma in situ (CIS) to measure the QOL. The ratio of QOL score functions for ICC and CIS patients were summed up over lifetime to obtain the duration of suffering from unsatisfactory HRQL. Jung-Der Wang MD, ScD, from the National Cheng Kung University Medical College and Hospital, lead author of the study, states, “In comparison with invasive cervical cancer, early detection of cervical neoplasm at the pre-cancer (carcinoma in situ, CIS) stage not only avoids 6.48 years of life loss, but also prevents reduction in HRQL in the long-run, leading to HRQL gains in the physical (1.71 years) and psychological (0.25 years) domains, as well as sexual life (1.47 years).”

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision-makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

Follow Value in Health on Twitter: @ISPORJournals

For more information: www.ispor.org

Related Stories

Rethinking Medication Adherence: A Stakeholder Blueprint

May 12, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a report from its Medication Adherence and Persistence Special Interest Group that provides valuable insights into the perspectives of key stakeholders on interventions to improve medication adherence. The report, “Stakeholders’ Perspectives on Medication Adherence Enhancing Interventions: An ISPOR Report,” was published in the May 2025 issue of Value in Health.

New Research Reveals Surprising Trends in Women's Health Economics Authorship

May 12, 2025

Value in Health, the official journal of ISPOR announced the publication of new research analyzing women's representation in authorship of papers submitted to and published in Value in Health. The report, “How Well Are Women Represented in Authorship in HEOR? An Analysis of Value in Health: An ISPOR Report,” was published in the May 2025 issue of Value in Health.

Redefining Value in Care for Alzheimer's Disease and Dementia

Apr 8, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of a special themed section of research papers that provide crucial insights into the complex health economics of Alzheimer's disease and related dementias (ADRD), offering a roadmap for future research and policy as the aging population grows and novel treatments emerge.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×